AZN
Price
$79.87
Change
-$0.12 (-0.15%)
Updated
Aug 29, 03:50 PM (EDT)
Capitalization
248.13B
69 days until earnings call
BAYZF
Price
$32.55
Change
-$0.65 (-1.96%)
Updated
Aug 25 closing price
Capitalization
32.49B
Interact to see
Advertisement

AZN vs BAYZF

Header iconAZN vs BAYZF Comparison
Open Charts AZN vs BAYZFBanner chart's image
AstraZeneca
Price$79.87
Change-$0.12 (-0.15%)
Volume$1.19K
Capitalization248.13B
Bayer A.G
Price$32.55
Change-$0.65 (-1.96%)
Volume$1.2K
Capitalization32.49B
AZN vs BAYZF Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. BAYZF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Buy and BAYZF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AZN: $79.99 vs. BAYZF: $32.55)
Brand notoriety: AZN: Notable vs. BAYZF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 66% vs. BAYZF: 21%
Market capitalization -- AZN: $248.13B vs. BAYZF: $32.49B
AZN [@Pharmaceuticals: Major] is valued at $248.13B. BAYZF’s [@Pharmaceuticals: Major] market capitalization is $32.49B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileBAYZF’s FA Score has 0 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • BAYZF’s FA Score: 0 green, 5 red.
According to our system of comparison, AZN is a better buy in the long-term than BAYZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 3 TA indicator(s) are bullish while BAYZF’s TA Score has 8 bullish TA indicator(s).

  • AZN’s TA Score: 3 bullish, 4 bearish.
  • BAYZF’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, BAYZF is a better buy in the short-term than AZN.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а -0.58% price change this week, while BAYZF (@Pharmaceuticals: Major) price change was +0.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.92%. For the same industry, the average monthly price growth was +1.24%, and the average quarterly price growth was +11.86%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.92% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($248B) has a higher market cap than BAYZF($32.5B). BAYZF YTD gains are higher at: 64.583 vs. AZN (24.690). AZN has higher annual earnings (EBITDA): 16.8B vs. BAYZF (6.84B). AZN has more cash in the bank: 7.11B vs. BAYZF (5.5B). AZN has less debt than BAYZF: AZN (32.8B) vs BAYZF (40.7B). AZN has higher revenues than BAYZF: AZN (56.5B) vs BAYZF (46.2B).
AZNBAYZFAZN / BAYZF
Capitalization248B32.5B763%
EBITDA16.8B6.84B246%
Gain YTD24.69064.58338%
P/E Ratio30.13N/A-
Revenue56.5B46.2B122%
Total Cash7.11B5.5B129%
Total Debt32.8B40.7B81%
FUNDAMENTALS RATINGS
AZN vs BAYZF: Fundamental Ratings
AZN
BAYZF
OUTLOOK RATING
1..100
2229
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
37100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4847
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZN's Valuation (24) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYZF (87) in the null industry. This means that AZN’s stock grew somewhat faster than BAYZF’s over the last 12 months.

AZN's Profit vs Risk Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYZF (100) in the null industry. This means that AZN’s stock grew somewhat faster than BAYZF’s over the last 12 months.

AZN's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as BAYZF (100) in the null industry. This means that AZN’s stock grew similarly to BAYZF’s over the last 12 months.

BAYZF's Price Growth Rating (47) in the null industry is in the same range as AZN (48) in the Pharmaceuticals Major industry. This means that BAYZF’s stock grew similarly to AZN’s over the last 12 months.

BAYZF's P/E Growth Rating (100) in the null industry is in the same range as AZN (100) in the Pharmaceuticals Major industry. This means that BAYZF’s stock grew similarly to AZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNBAYZF
RSI
ODDS (%)
Bearish Trend 2 days ago
38%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 10 days ago
54%
Bullish Trend 12 days ago
63%
Declines
ODDS (%)
Bearish Trend 22 days ago
44%
Bearish Trend 30 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DUSL74.720.27
+0.36%
Direxion Dly Industrials Bull 3X ShsETF
SAWG20.84N/A
N/A
AAM Sawgrass U.S. Lg Cp Qual Gr ETF
VTEI98.87N/A
N/A
Vanguard Intermediate-Term Tx-Exm Bd ETF
COWZ57.93-0.02
-0.03%
Pacer US Cash Cows 100 ETF
APMU24.94-0.01
-0.04%
ActivePassive Intermediate Mcpl Bd ETF

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
+0.08%
GSK - AZN
63%
Loosely correlated
-1.18%
NVS - AZN
61%
Loosely correlated
-0.33%
SNY - AZN
50%
Loosely correlated
-0.34%
AZNCF - AZN
48%
Loosely correlated
-1.53%
PFE - AZN
47%
Loosely correlated
-1.87%
More

BAYZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYZF has been closely correlated with BAYRY. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYZF jumps, then BAYRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYZF
1D Price
Change %
BAYZF100%
N/A
BAYRY - BAYZF
88%
Closely correlated
-0.97%
AZN - BAYZF
20%
Poorly correlated
+0.08%
GIFOF - BAYZF
12%
Poorly correlated
N/A
CSPCY - BAYZF
12%
Poorly correlated
-2.57%
CHGCY - BAYZF
11%
Poorly correlated
+1.76%
More